The FDA also authorized the Roche Elecsys HBsAg II quant II RxDx assay as a companion diagnostic device to aid in the ...
Dr. Norah Terrault, Chief of Gastroenterology & Hepatology, USC Keck Medical Center, said: “This is the start of a new era in treating people living with CHB. Bepirovirsen offers patients the ...
GSK plc announced that the US Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen) to treat chronic hepatitis B (CHB) virus infection in combination with nucleos ...
MedPage Today on MSN
Study warns of more chronic hepatitis B in the years ahead
Shift to shared decision-making for vaccine recommendation would up chronic infections by ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced that the U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen) for the treatment of chronic hepatitis B ...
The FDA on Tuesday approved bepirovirsen (Hibsago) as a potential functional cure for adults with chronic hepatitis B, but ...
A high-sensitivity molecular study of 13 mother–child pairs found that 84.6% of infants who received enhanced hepatitis B ...
FDA-approved Hibsago could help some adults with chronic hepatitis B stop antiviral therapy. Learn who qualifies, what trials found, and the key risks.
Chronic hepatitis B virus (HBV) infections can cause life-threatening liver disease. Before December 2025, the Centers for Disease Control recommended ...
A simple test that changes color when it detects hepatitis B virus DNA could bring molecular diagnosis out of centralized ...
The International Agency for Research on Cancer (IARC) of the World Health Organization has classified hepatitis D virus (HDV) as carcinogenic, citing sufficient evidence and placing it alongside ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results